Physiopathology of acne vulgaris: recent data, new understanding of the treatments.
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology*; D000284:Administration, Oral; D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D008297:Male; D012176:Retinoids / Q000627:therapeutic use*; D012307:Risk Factors; D012627:Sebaceous Glands / Q000378:metabolism*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D003879:Dermatologic Agents; D007641:Keratolytic Agents; D012176:Retinoids